Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI ratsS. John Weroha(Mayo Clinic), Jonathan J. Li(Thomas Jefferson University)CarcinogenesisNovember 25, 200510.1093/carcin/bgi278Cited by 39SaveCiteExport RISWatch citationsRelated PapersA Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies|Clinical Cancer Research|2024|15Supplementary Table S1 from A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies|Unknown|2024|0Data from A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies|Unknown|2024|0Supplementary Figure S1 from A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies|Unknown|2024|0Supplementary Table S1 from A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies|Unknown|2024|0